Percutaneous vertebroplasty for neoplastic vertebral compression fractures in patients with spinal metastases: a single-center retrospective case series

Abstract Background: Neoplastic vertebral compression fractures resulting from spinal metastases substantially impair health-related quality of life in patients with cancer. Identifying a safe, minimally invasive palliative option to relieve mechanical pain in this population remains a clinical challenge. Objective:To assess the intermediate-to-long-term clinical outcomes of percutaneous vertebroplasty (PVP) for pathological vertebral compression fractures in patients with spinal metastases, with a focus on pain relief and functional improvement. Methods: We retrospectively reviewed 89 patients with histologically confirmed solid tumors and imaging-confirmed spinal metastases who underwent PVP for painful neoplastic vertebral compression fractures between 2018 and 2023. All procedures were performed under local anesthesia and fluoroscopic guidance. Visual analogue scale (VAS), Oswestry Disability Index (ODI), analgesic use, cement leakage, complications, and local recurrence were recorded. Follow-up was based on outpatient and imaging records. Results: 89 patients (male 48, female 41; mean age 62.03 ± 2.17 years) were included. Mean follow-up was 36 months. VAS decreased from 7.71 ± 1.11 preoperatively to 5.82 ± 1.34 at 1 month and remained improved at last follow-up (median 36 months). ODI improved from 52.0% ± 8.3% preoperatively to 28.4% ± 6.7%. HAMA decreased from 18.2 ± 4.6 preoperatively to 11.3 ± 3.8 at 1 month (P<0.05). Cement leakage was observed in 23 patients (25.8%), all asymptomatic. No pulmonary cement embolism or neurological deterioration occurred. All patients received subsequent radiotherapy, chemotherapy, or systemic therapy according to the original oncologic treatment plan after PVP. Local progression at the index level, including adjacent-level refracture in 3 cases, was observed in 5 cases. Conclusion: At intermediate-to-long-term follow-up (mean 36 months), pain scores and functional status remained improved compared with baseline in this cohort of spinal metastasis patients treated with PVP for pathological vertebral compression fractures. PVP appears acceptable for intermediate-to-long-term palliation in carefully selected cases, pending validation in larger comparative studies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11420961/v1
Primary Topic
Management of metastatic bone disease
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Percutaneous vertebroplasty for neoplastic vertebral compression fractures in patients with spinal metastases: a single-center retrospective case series

Sheng Sun, Lu Li, Jian Qi, Qian Gao
Research Square
Management of metastatic bone disease
preprint

Percutaneous vertebroplasty for neoplastic vertebral compression fractures in patients with spinal metastases: a single-center retrospective case series

Sheng Sun, Lu Li, Jian Qi, Qian Gao
preprint en

Abstract

Abstract Background: Neoplastic vertebral compression fractures resulting from spinal metastases substantially impair health-related quality of life in patients with cancer. Identifying a safe, minimally invasive palliative option to relieve mechanical pain in this population remains a clinical challenge. Objective:To assess the intermediate-to-long-term clinical outcomes of percutaneous vertebroplasty (PVP) for pathological vertebral compression fractures in patients with spinal metastases, with a focus on pain relief and functional improvement. Methods: We retrospectively reviewed 89 patients with histologically confirmed solid tumors and imaging-confirmed spinal metastases who underwent PVP for painful neoplastic vertebral compression fractures between 2018 and 2023. All procedures were performed under local anesthesia and fluoroscopic guidance. Visual analogue scale (VAS), Oswestry Disability Index (ODI), analgesic use, cement leakage, complications, and local recurrence were recorded. Follow-up was based on outpatient and imaging records. Results: 89 patients (male 48, female 41; mean age 62.03 ± 2.17 years) were included. Mean follow-up was 36 months. VAS decreased from 7.71 ± 1.11 preoperatively to 5.82 ± 1.34 at 1 month and remained improved at last follow-up (median 36 months). ODI improved from 52.0% ± 8.3% preoperatively to 28.4% ± 6.7%. HAMA decreased from 18.2 ± 4.6 preoperatively to 11.3 ± 3.8 at 1 month (P<0.05). Cement leakage was observed in 23 patients (25.8%), all asymptomatic. No pulmonary cement embolism or neurological deterioration occurred. All patients received subsequent radiotherapy, chemotherapy, or systemic therapy according to the original oncologic treatment plan after PVP. Local progression at the index level, including adjacent-level refracture in 3 cases, was observed in 5 cases. Conclusion: At intermediate-to-long-term follow-up (mean 36 months), pain scores and functional status remained improved compared with baseline in this cohort of spinal metastasis patients treated with PVP for pathological vertebral compression fractures. PVP appears acceptable for intermediate-to-long-term palliation in carefully selected cases, pending validation in larger comparative studies.

Research Square
Capital Medical University (CN), Chinese People's Liberation Army (CN), Jinzhou Medical University (CN)
Natural Science Foundation of Shandong Province
Good health and well-being
Management of metastatic bone disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon